Logo video2dn
  • Сохранить видео с ютуба
  • Категории
    • Музыка
    • Кино и Анимация
    • Автомобили
    • Животные
    • Спорт
    • Путешествия
    • Игры
    • Люди и Блоги
    • Юмор
    • Развлечения
    • Новости и Политика
    • Howto и Стиль
    • Diy своими руками
    • Образование
    • Наука и Технологии
    • Некоммерческие Организации
  • О сайте

Видео ютуба по тегу Precigen Gene Therapy

FDA Gave Precigen (PGEN) a Monopoly in This Market and Competitors Are Running Out of Time
FDA Gave Precigen (PGEN) a Monopoly in This Market and Competitors Are Running Out of Time
PGEN Decision Looms as Controversy Erupts Between Trump & FDA
PGEN Decision Looms as Controversy Erupts Between Trump & FDA
Precigen (PGEN) Gene Therapy Pipeline Explained: PRGN-2012, AdenoVerse, and Market Potential
Precigen (PGEN) Gene Therapy Pipeline Explained: PRGN-2012, AdenoVerse, and Market Potential
Precigen Buyout Coming? Why Big Pharma May Be Watching PGEN Closely
Precigen Buyout Coming? Why Big Pharma May Be Watching PGEN Closely
Reimagining Gene and Cell Therapy: Helen Sabzevari on Precigen’s Breakthroughs in Precision...
Reimagining Gene and Cell Therapy: Helen Sabzevari on Precigen’s Breakthroughs in Precision...
The Future of Adenovector-Based Therapies with Precigen's Helen Sabzevari, Ph.D.
The Future of Adenovector-Based Therapies with Precigen's Helen Sabzevari, Ph.D.
Precigen
Precigen
Precigen AdenoVerse®: Advancing Targeted AdenoVerse Immunotherapies
Precigen AdenoVerse®: Advancing Targeted AdenoVerse Immunotherapies
Precigen
Precigen
Precigen UltraCAR-T®: Advancing Personalized CAR-T Therapies
Precigen UltraCAR-T®: Advancing Personalized CAR-T Therapies
Cell Therapy Platform Dev With Precigen CEO Dr. Helen Sabzevari
Cell Therapy Platform Dev With Precigen CEO Dr. Helen Sabzevari
Precigen - Maryland Success Story
Precigen - Maryland Success Story
Следующая страница»
  • О нас
  • Контакты
  • Отказ от ответственности - Disclaimer
  • Условия использования сайта - TOS
  • Политика конфиденциальности

video2dn Copyright © 2023 - 2025

Контакты для правообладателей [email protected]